AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27057659 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication for comorbid depression
Number of subjects: 193
Study 24129597 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.075 mg administered before induction of anaesthesia (pre-surgery group, n=50)
Number of subjects: 100
Study 24129597 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.075 mg administered after surgery in the recovery room (post-surgery group, n=50)
Number of subjects: 100
Study 23017153 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous outpatient interdisciplinary rehabilitation programme (once weekly sessions)
Number of subjects: 100
Study 23017153 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study 20385971 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (low-dose: 2.5 or 5 mg; high-dose: 20 or 40 mg)
Number of subjects: 0
Study 20385971 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (continued therapy)
Number of subjects: 0
Study 20385971 — intervention group
Group type: COMPARATOR
Intervention: Placebo (washout)
Number of subjects: 0
Study 18359175 — intervention group
Group type: EXPERIMENTAL
Intervention: 2mg oral micronized estradiol (E2) (n=25)
Number of subjects: 77
Study 18359175 — intervention group
Group type: EXPERIMENTAL
Intervention: 2mg oral E2 + 1mg oral norethisterone acetate (NETA) (n=28)
Number of subjects: 77
Study 18359175 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=24)
Number of subjects: 77
Study 16093400 — intervention group
Group type: EXPERIMENTAL
Intervention: Yam (Dioscorea alata) 390 g in 2 of 3 meals per day for 30 days
Number of subjects: 24
Study 16093400 — intervention group
Group type: COMPARATOR
Intervention: Sweet potato 240 g for 41 days (control)
Number of subjects: 24
Study 12506292 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic technique (LT)
Number of subjects: 60
Study 12506292 — intervention group
Group type: COMPARATOR
Intervention: Open technique (OT)
Number of subjects: 60
Study 10099888 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulating bacterial extract (IBE)
Number of subjects: 40
Study 10099888 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 40
Study 8672605 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsapirone (0.5 mg/kg orally)
Number of subjects: 32
Study 8672605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 8672605 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsapirone
Number of subjects: 32
Study 2216186 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound reclosure by a standardized en bloc technique (35 patients)
Number of subjects: 41
Study 2216186 — intervention group
Group type: COMPARATOR
Intervention: Healing by second intention (6 patients)
Number of subjects: 41
Study 387492 — intervention group
Group type: EXPERIMENTAL
Intervention: Finorgal (ethchlorvynol with diphenhydramine)
Number of subjects: 35
Study 387492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 31978543 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural music stimuli (unedited songs)
Number of subjects: 48
Study 31978543 — intervention group
Group type: EXPERIMENTAL
Intervention: Measure-shuffled versions of music
Number of subjects: 48
Study 31978543 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency-domain measures of correlation (coherence)
Number of subjects: 48
Study 31978543 — intervention group
Group type: COMPARATOR
Intervention: Phase-scrambled controls
Number of subjects: 48
Study 31317511 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence-contingent rebates
Number of subjects: 100
Study 31317511 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no rebates)
Number of subjects: 100
Study 28350753 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie dinners (British, German, Italian with alcohol)
Number of subjects: 84
Study 28350753 — intervention group
Group type: COMPARATOR
Intervention: Low-fat, low-calorie Czech dinner
Number of subjects: 84
Study 28350753 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat, high-calorie British dinner
Number of subjects: 84
Study 28350753 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meals
Number of subjects: 84
Study 25264014 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping with 35-40% stretch
Number of subjects: 14
Study 25264014 — intervention group
Group type: COMPARATOR
Intervention: Kinesiology taping without stretch
Number of subjects: 14
Study 23514765 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain and fiber-rich rye breads
Number of subjects: 51
Study 23514765 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat breads
Number of subjects: 51
Study 21474481 — intervention group
Group type: EXPERIMENTAL
Intervention: Sidecar crib
Number of subjects: 1204
Study 21474481 — intervention group
Group type: COMPARATOR
Intervention: Standalone cot
Number of subjects: 1204
Study 19622121 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined betamethasone dipropionate and calcipotriol
Number of subjects: 30
Study 19622121 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone dipropionate
Number of subjects: 30
Study 19622121 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol
Number of subjects: 30
Study 19622121 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (betamethasone dipropionate and calcipotriol)
Number of subjects: 30
Study 16920219 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain removal at 24 hours
Number of subjects: 0
Study 16920219 — intervention group
Group type: COMPARATOR
Intervention: Drain removal at 72 hours
Number of subjects: 0
Study 12872081 — intervention group
Group type: EXPERIMENTAL
Intervention: Suck-and-ligate device without prior submucosa injection
Number of subjects: 72
Study 12872081 — intervention group
Group type: COMPARATOR
Intervention: Cap technique with prior submucosa injection of dilute saline solution of epinephrine
Number of subjects: 72
Study 8731701 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal antiinflammatory drugs (NSAIDs)
Number of subjects: 0
Study 1525801 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (500 mg, single oral dose)
Number of subjects: 10
Study 1525801 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in 4 migraine patients)
Number of subjects: 10
Study 1525801 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (n=5)
Number of subjects: 10
Study 3902675 — intervention group
Group type: EXPERIMENTAL
Intervention: KB-944 100 mg/day
Number of subjects: 20
Study 3902675 — intervention group
Group type: EXPERIMENTAL
Intervention: KB-944 200 mg/day
Number of subjects: 20
Study 3902675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30187284 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium selenite (SS) 400 μg
Number of subjects: 24
Study 30187284 — intervention group
Group type: EXPERIMENTAL
Intervention: Se-methylselenocysteine (MSC) 400 μg
Number of subjects: 24
Study 30187284 — intervention group
Group type: EXPERIMENTAL
Intervention: Seleno-l-methionine (SLM) 400 μg
Number of subjects: 24
Study 30187284 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 24
Study 28853492 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical aprepitant
Number of subjects: 0
Study 28853492 — intervention group
Group type: COMPARATOR
Intervention: Placebo vehicle
Number of subjects: 0
Study 26354741 — intervention group
Group type: EXPERIMENTAL
Intervention: Open pleurae, collapsed lungs and conventional pulmonary perfusion and ventilation
Number of subjects: 20
Study 26354741 — intervention group
Group type: COMPARATOR
Intervention: Intact pleurae, expanded lungs and gradual pulmonary perfusion and ventilation
Number of subjects: 20
Study 24176927 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with computer-assisted cognitive training
Number of subjects: 40
Study 24176927 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS combined with computer-assisted cognitive training
Number of subjects: 40
Study 22129066 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropattern diagnostics provided to physicians (experimental group, n=51)
Number of subjects: 101
Study 22129066 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment without NP diagnostics (control group, n=50)
Number of subjects: 101
Study 20471248 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed/carboplatin
Number of subjects: 402
Study 20471248 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine/carboplatin
Number of subjects: 402
Study 17505919 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART along with syphilis and herpes simplex virus type 2 (HSV-2) treatment
Number of subjects: 350
Study 17505919 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing condom use
Number of subjects: 350
Study 15661440 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (fear reducing and activating techniques)
Number of subjects: 240
Study 15661440 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 240
Study 11940726 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/d fasting before breakfast
Number of subjects: 80
Study 11940726 — intervention group
Group type: COMPARATOR
Intervention: Alendronate 10 mg/d fasting at noon before lunch
Number of subjects: 80
Study 10655440 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder telephone call
Number of subjects: 1765
Study 10655440 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational telephone call addressing barriers
Number of subjects: 1765
Study 10655440 — intervention group
Group type: COMPARATOR
Intervention: Reminder post‐card
Number of subjects: 1765
Study 10655440 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior mammography
Number of subjects: 1765
Study 8880611 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental diet (EN-9305)
Number of subjects: 20
Study 8880611 — intervention group
Group type: COMPARATOR
Intervention: Control diet (Osmolyte HN)
Number of subjects: 20
Study 1947851 — intervention group
Group type: EXPERIMENTAL
Intervention: ESWL treatment by experienced surgeons (group A)
Number of subjects: 89
Study 1947851 — intervention group
Group type: COMPARATOR
Intervention: ESWL treatment by inexperienced surgeons (group B)
Number of subjects: 89
Study 6716324 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic clinical assessment during admission and a few weeks after return home
Number of subjects: 229
Study 6716324 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple regression analysis of information obtained during the acute hospital admission
Number of subjects: 229
Study 6716324 — intervention group
Group type: EXPERIMENTAL
Intervention: Early findings
Number of subjects: 229
Study 31365044 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol patch (200-μg)
Number of subjects: 200
Study 31365044 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 200
Study 27658997 — intervention group
Group type: EXPERIMENTAL
Intervention: NuStat® hemostatic dressing
Number of subjects: 20
Study 27658997 — intervention group
Group type: COMPARATOR
Intervention: Historic standard of care
Number of subjects: 20
Study 24149761 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training with 24 hours of rest (PT24)
Number of subjects: 166
Study 24149761 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training with 48 hours of rest (PT48)
Number of subjects: 166
Study 24149761 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 166
Study 23200084 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg)
Number of subjects: 18
Study 23200084 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg)
Number of subjects: 18
Study 23200084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 21541727 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with PKU
Number of subjects: 64
Study 21541727 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher lifetime Phe levels
Number of subjects: 64
Study 21541727 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher lifetime Phe levels and Index of Dietary Control (IDC)
Number of subjects: 64
Study 21541727 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of dietary control
Number of subjects: 64
Study 18201203 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 273
Study 18201203 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg
Number of subjects: 273
Study 18201203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study 16549261 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 0
Study 16549261 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized Alzheimer's Disease Assessment Scale cognitive subscale
Number of subjects: 0
Study 16549261 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled index of six outcome measures
Number of subjects: 0
Study 16549261 — intervention group
Group type: COMPARATOR
Intervention: Individual measures
Number of subjects: 0
Study 15642722 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (150 ml, 15 g alcohol)
Number of subjects: 87
Study 15642722 — intervention group
Group type: COMPARATOR
Intervention: Abstention from alcohol
Number of subjects: 87
Study 10979918 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (2 sequential doses of 400 mg)
Number of subjects: 0
Study 10979918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9295004 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol-17beta (100 mg/day)
Number of subjects: 16
Study 9295004 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 16
Study 8333745 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy (CDDP 50 mg/m2 + VDS 3 mg/m2)
Number of subjects: 30
Study 8333745 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy (30 Gray)
Number of subjects: 30
Study 8333745 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy (CDDP + VDS)
Number of subjects: 30
Study 8333745 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 30
Study 2883273 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 5
Study 2883273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 2722305 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic induction and suggestions derived from Rational‐Emotive Therapy, 4 weekly treatment sessions
Number of subjects: 40
Study 2722305 — intervention group
Group type: COMPARATOR
Intervention: Discussion of stress reduction methods (Control)
Number of subjects: 40
Study 29514344 — intervention group
Group type: EXPERIMENTAL
Intervention: mCare (standard care management plus mCare)
Number of subjects: 182
Study 29514344 — intervention group
Group type: COMPARATOR
Intervention: Standard care management alone (control)
Number of subjects: 182
Study 29514344 — intervention group
Group type: EXPERIMENTAL
Intervention: mCare
Number of subjects: 182
Study 29514344 — intervention group
Group type: COMPARATOR
Intervention: Standard care management
Number of subjects: 182
Study 28636208 — intervention group
Group type: COMPARATOR
Intervention: PRN1008 (50-1200 mg single dose)
Number of subjects: 6
Study 28636208 — intervention group
Group type: COMPARATOR
Intervention: PRN1008 (300-900 mg daily for 10 days)
Number of subjects: 6
Study 28636208 — intervention group
Group type: COMPARATOR
Intervention: PRN1008 (single and multiple doses)
Number of subjects: 6
Study 26142048 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori vaccine
Number of subjects: 4464
Study 26142048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4464
Study 24170762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fiber (quartiles from 8.7 to 21.8 g)
Number of subjects: 1414
Study 24170762 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetables and fruits (quartiles from 228.7 to 721.4 g)
Number of subjects: 1414
Study 24170762 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble dietary fiber (per 1-g increase)
Number of subjects: 1414
Study 24170762 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dietary fiber (per 1-g increase)
Number of subjects: 1414
Study 24170762 — intervention group
Group type: EXPERIMENTAL
Intervention: Insoluble dietary fiber (per 1-g increase)
Number of subjects: 1414
Study 21939839 — intervention group
Group type: EXPERIMENTAL
Intervention: Canrenone
Number of subjects: 146
Study 21939839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 18335698 — intervention group
Group type: EXPERIMENTAL
Intervention: EpiCor (500 mg daily)
Number of subjects: 116
Study 18335698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 16584855 — intervention group
Group type: COMPARATOR
Intervention: Seretide Diskus (salmeterol xinafoate 50 mcg; fluticasone propionate 500 mcg)
Number of subjects: 20
Study 16584855 — intervention group
Group type: COMPARATOR
Intervention: Symbicort Turbuhaler (formoterol 6 mcg; budesonide 200 mcg)
Number of subjects: 20
Study 16584855 — intervention group
Group type: COMPARATOR
Intervention: Symbicort Turbuhaler
Number of subjects: 20
Study 14977304 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl) without prior immersion of contaminated files (Group I)
Number of subjects: 28
Study 14977304 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl) with prior immersion of contaminated files for 10 seconds (Group II)
Number of subjects: 28
Study 14977304 — intervention group
Group type: COMPARATOR
Intervention: Sterile files (Negative Control Group)
Number of subjects: 28
Study 14977304 — intervention group
Group type: COMPARATOR
Intervention: Contaminated patency files in teeth with empty canals (First Positive Control Group)
Number of subjects: 28
Study 14977304 — intervention group
Group type: COMPARATOR
Intervention: Contaminated files placed into broth next to teeth filled with NaOCl (Second Positive Control Group)
Number of subjects: 28
Study 11688199 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone reminder
Number of subjects: 2304
Study 11688199 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcard reminder
Number of subjects: 2304
Study 11688199 — intervention group
Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 2304
Study 9106854 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence Reading Condition
Number of subjects: 0
Study 9106854 — intervention group
Group type: COMPARATOR
Intervention: Word Reading Condition
Number of subjects: 0
Study 9106854 — intervention group
Group type: COMPARATOR
Intervention: Syllable Reading Condition
Number of subjects: 0
Study 7684351 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (subcutaneous injection, single fixed daily dose)
Number of subjects: 0
Study 7684351 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 0
Study 7684351 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulants
Number of subjects: 0
Study 7684351 — intervention group
Group type: COMPARATOR
Intervention: Dextron
Number of subjects: 0
Study 3544755 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside at an initial rate of 1.3 micrograms/kg/min
Number of subjects: 20
Study 3544755 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine at an initial rate of 0.7 micrograms/kg/min
Number of subjects: 20
Study 3544755 — intervention group
Group type: COMPARATOR
Intervention: Control measurements obtained 10 minutes after intubation
Number of subjects: 20
Study 29572400 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus supported self-management delivered by community palliative care nurses
Number of subjects: 160
Study 29572400 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study 29572400 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus supported self-management
Number of subjects: 160
Study 26608839 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet application for 60 minutes
Number of subjects: 10
Study 26608839 — intervention group
Group type: COMPARATOR
Intervention: Non-tourniquet group
Number of subjects: 10
Study 24522170 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily insulin detemir (initiated with mean 0.12 U/kg)
Number of subjects: 50
Study 24522170 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily insulin detemir (initiated with mean 0.12 U/kg)
Number of subjects: 50
Study 19828278 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine HIV testing program in the emergency department (ED)
Number of subjects: 108
Study 20142027 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed NYHA class (SA-NYHA)
Number of subjects: 293
Study 18678159 — intervention group
Group type: EXPERIMENTAL
Intervention: Yan three needling group (EA at three acupoints of eye: Jingming, Shangming, Chengqi)
Number of subjects: 76
Study 18678159 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture group (EA at routinely selected acupoints: Yifeng, Dicang, etc.)
Number of subjects: 76
Study 15976218 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (Ce50 5.0 ng/mL) during tracheal intubation (group TI, n = 20)
Number of subjects: 41
Study 15976218 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (Ce50 2.1 ng/mL) during skin incision (group SI, n = 21)
Number of subjects: 41
Study 12804052 — intervention group
Group type: COMPARATOR
Intervention: Zevalin (ibritumomab tiuxetan) regimen including 5 mCi (111)In-labeled Zevalin on Day 1 and 0.4 mCi/kg (90)Y Zevalin on Day 8, preceded by 250 mg/m(2) rituximab.
Number of subjects: 143
Study 12804052 — intervention group
Group type: COMPARATOR
Intervention: Zevalin (ibritumomab tiuxetan) regimen
Number of subjects: 143
Study 11085661 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergic skin diseases (55%)
Number of subjects: 1000
Study 11085661 — intervention group
Group type: EXPERIMENTAL
Intervention: Infections (33%)
Number of subjects: 1000
Study 11085661 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodermatosis (8%)
Number of subjects: 1000
Study 11085661 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopic dermatitis (47% of allergic skin diseases)
Number of subjects: 1000